Meridian Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,033	Closed	-$596K	–	176
2024 Q3	$596K	Sell	9,033 -22,584	-71%	-$1.64M	0.1%	101
2024 Q2	$2.92M	Buy	31,617 +846	+3%	+$74.9K	0.52%	47
2024 Q1	$2.94M	Buy	30,771 +3,082	+11%	+$259K	0.55%	44
2023 Q4	$2.11M	Sell	27,689 -90	-0.3%	-$6.26K	0.46%	54
2023 Q3	$1.92M	Sell	27,779 -800	-3%	-$64.3K	0.48%	53
2023 Q2	$2.7M	Buy	28,579 +1,233	+5%	+$107K	0.65%	44
2023 Q1	$2.26M	Buy	27,346 +4,253	+18%	+$334K	0.57%	47
2022 Q4	$1.72M	Buy	23,093 +436	+2%	+$33.6K	0.44%	56
2022 Q3	$1.87M	Sell	22,657 -3,410	-13%	-$328K	0.53%	44
2022 Q2	$2.48M	Buy	26,067 +944	+4%	+$97.7K	0.66%	39
2022 Q1	$2.96M	Buy	25,123 +2,254	+10%	+$253K	0.69%	37
2021 Q4	$2.96M	Buy	22,869 +2,524	+12%	+$294K	0.72%	33
2021 Q3	$2.3M	Buy	20,345 +1,081	+6%	+$123K	0.64%	35
2021 Q2	$2M	Buy	19,264 +5,548	+40%	+$523K	0.56%	43
2021 Q1	$1.15M	Buy	13,716 +4,977	+57%	+$421K	0.38%	63
2020 Q4	$797K	Buy	+8,739	New	+$725K	0.29%	76